Article
Encore: Is lecanemab the Alzheimer's drug that will finally make a difference?
Rating:
0.0
Views:
51
Likes:
1
Library:
1
Researchers say the experimental Alzheimer's drug Lecanemab represents an important advance and is likely to get FDA approval in 2023, despite some safety concerns.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value